Exo Therapeutics Revenue

Biotechnology Research • Cambridge, Massachusetts, United States • 11-20 Employees

Exo Therapeutics revenue & valuation

Annual revenue	$1,400,000
Revenue per employee	$78,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,500,000
Total funding	No funding

Key Contacts at Exo Therapeutics

Alan Saghatelian

Co-Founder

Bhavatarini Vangamudi

Sr. Director

Matthew Martin

Senior Director, Medicinal Chemistry

Wes Westlin

Board Of Director

Company overview

Headquarters	150 Cambridge Park Dr, Suite 300, Cambridge, Massachusetts 02140, US
Website	exo-therapeutics.com
NAICS	541714
Founded	2018
Employees	11-20
Socials

Exo Therapeutics Email Formats

Exo Therapeutics uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@exo-therapeutics.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@exo-therapeutics.com	100%

About Exo Therapeutics

Exo Therapeutics is a small molecule drug discovery and development company with a pioneering technology to address intractable pharmaceutical targets. By leveraging the company’s ExoSightTM platform, Exo is developing a deep pipeline of potent drug candidates that bind exosites, distal and unique binding pockets that have the potential to reprogram enzyme activity for precise and robust therapeutic effect. Through this specific and selective approach to challenging targets, the company’s team of world-class researchers is unlocking breakthrough therapeutics in oncology, inflammation and a broad range of other diseases.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Director

Founder/Owner

Employees by Department

Exo Therapeutics has 6 employees across 5 departments.

Departments

Number of employees

Funding Data

Exo Therapeutics has never raised funding before.

Frequently asked questions

Exo Therapeutics is located in Cambridge, Massachusetts, US.

Exo Therapeutics generates an estimated annual revenue of $1,400,000. This revenue figure reflects the company's market position and business performance in its industry.

Exo Therapeutics has an estimated valuation of $4,500,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Exo Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Exo Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.